DRKS00003304
Completed
Not Applicable
Identification of biomarkers, functional parameters and clinical risk factors predisposing for the development of pulmonary chronic GVHD after allogeneic hematopoietic stem cell transplantation.
Westdeutsches TumorzentrumKlinik für KnochenmarktransplantationUniversitätsklinikum Essen0 sites125 target enrollmentNovember 2, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- obliterative bronchiolitis, bronchiolitis obliterans with organizing pneumonia (BOOP), non-classifiable interstitial pneumonia (NCIP)chronic GVHD, ICD-10: T86.05, T86.06, T86.07
- Sponsor
- Westdeutsches TumorzentrumKlinik für KnochenmarktransplantationUniversitätsklinikum Essen
- Enrollment
- 125
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •free of relapse after allogeneic HSCT
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Identification of genetic and functional biomarkers that predict PPAR-gamma-associated fluid retention and oedemaEUCTR2008-001634-28-GBniversity of Dundee
Recruiting
Not Applicable
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-Part Research: Part BF00.2Alzheimer's diseaseMild Cognitive ImpairmentF00.0F00.1F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorderDRKS00003705QUALISSIMA150
Completed
Not Applicable
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a two-part clinical study. Part A: Multisite MRI Acquisition - Protocol Harmonization Part B: Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a clinical studyNL-OMON38870Vrije Universiteit Medisch Centrum15
Completed
Not Applicable
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-part Research: Part AHealthy SubjectsMild Cognitive ImpairmentAlzheimer's disease / Alzheimer dementiaF00.0F00.1F00.2F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorderDRKS00003721QUALISSIMA40
Recruiting
Not Applicable
Identification of biomarker and clarification of resistance mechanism in immune checkpoint inhibitor therapyon-small cell lung cancer Kidney cancer Malignant melanoma Classical Hodgkin's lymphoma Head and neck cancer Gastric cancer Urothelial cancer Microsatellite instability-high (MSI-H) solid tumorJPRN-UMIN000027091Kanagawa Cancer Center Research Institute560